Avricore Health Corporate Update – Company Demonstrates Strong Growth
VANCOUVER, BRITISH COLUMBIA – November 30, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) reports on its third quarter results which demonstrate significant growth in pharmacy locations offering HealthTab™ driving strong revenue growth and operational cashflow positivity. With demand for clinical services growing in pharmacies thanks to the ever-expanding scope and demonstrated […]
HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic
VANCOUVER, BC, Sept. 19, 2023 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is expanding its innovative point-of-care chronic and infectious disease screening and health-data management platform, HealthTab™, further into the Canadian pharmacy ecosystem with one of Canada’s largest pharmacy retailers, Rexall Pharmacy Group ULC (“Rexall”). “With Pharmacies’ expanded scope […]
Avricore Health Corporate Update – Mid-year Review Demonstrates Company on Right Track
VANCOUVER, BRITISH COLUMBIA – August 30, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) continues to achieve significant growth, new partnerships and developing new markets while surpassing margin targets. Now, as the Company looks back at the first half of the year, it continues with confidence on its strategy to bring HealthTab™, […]
HealthTab™ Signs Reseller Agreement With Abbott To Support UK Expansion
VANCOUVER, BC – (GLOBE NEWSWIRE) –August 08, 2023– Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a reseller agreement between HealthTab™ Inc. and Abbott Rapid Dx UK & Ireland. This agreement provides a foundation for HealthTab to purchase and distribute the Afinion™ 2 and associated tests for diabetes […]
Avricore’s HealthTab Selected For Feasibility Study For Testing In Community Pharmacies In United Kingdom
VANCOUVER, BC – (GLOBE NEWSWIRE) – August 8, 2023 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased that HealthTab™, the Company’s leading pharmacy-based platform for testing and health data management, has been selected by a collaborative involving the internationally renowned Barts Heart Centre and HEART UK to assess the feasibility of community pharmacists in […]
HealthTab™ To Integrate Contour®Next Family of Blood Glucose Meters To Offer Deeper Diabetes Patient Insights
VANCOUVER, BC – (GLOBE NEWSWIRE) – July 19, 2023 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce its agreement with Ascensia Diabetes Care, a global diabetes care company, to integrate their blood glucose monitoring (BGM) systems, marketed as CONTOUR®NEXT GEN and CONTOUR®NEXT ONE, with Avricore’s pharmacy-based point-of-care testing (POCT) platform, HealthTab™. Ascensia […]
Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
VANCOUVER, BRITISH COLUMBIA – June 21, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) held its annual general meeting to elect directors, appoint its auditor and accept a new stock option plan to support the company’s continued growth. “It’s been another amazing year of significant growth and accomplishments and everyone on the […]
Avricore Grants Options
VANCOUVER, BRITISH COLUMBIA – May 15, 2023 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 1,625,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD […]
Avricore Health Corporate Updates On Audited Results For 2022
The Company will host an investor update call on May 3rd with CEO Hector Bremner to share the Company’s outlook and take questions. VANCOUVER, BRITISH COLUMBIA – May 02, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) today is pleased to announce its audited final results for 2022. The Company achieved record […]
Avricore Health’s HealthTab™ Passes 530 Locations, Adds Virus Detection
VANCOUVER, BRITISH COLUMBIA – March 23, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching 532 locations. In 100 of these locations, the Company will be deploying Abbott’s ID Now™, either in combination with the Afinion 2™ or standalone, to support virus detection […]
